Table 1.
Characteristics of patients in the study cohort.
| AML | T-ALL | MPAL, T/B | AUL | Total | |
|---|---|---|---|---|---|
| Sex | 1F | 9M | 0F | 8M | 1F | 0M | 0F | 1M | 2F | 18M |
| Age (years) | |||||
| 1–9 | 0 | 3 | 1 | 0 | 4 |
| 10–20 | 10 | 5 | 0 | 1 | 16 |
| WBC count | |||||
| >100,000 | 4 | 1 | 5 | ||
| <100,000 | 5 | 7 | 12 | ||
| N/A | 1 | 1 | 1 | 3 | |
| Extramedullary disease | |||||
| Yes | 7 | 6 | 13 | ||
| No | 3 | 1 | 1 | 1 | 6 |
| N/A | 1 | 1 | |||
| Refractory/Relapse | |||||
| Yes | 10 | 1 | 1 | 1 | 13 |
| No | 0 | 7 | 7 | ||
| Survival | |||||
| Deceased | 8 | 1* | 1 | 1 | 11 |
| Alive | 2 | 6 | 8 | ||
| Lost to Follow Up | 1 | 1 | |||
| Total # patients | 10 | 8 | 1 | 1 | 20 |
*
The patient died of sepsis during induction therapy
Abbreviations: AML, Acute myeloid leukemia; AUL, acute undifferentiated leukemia; F, female; M, male; MPAL, mixed-phenotype acute leukemia; N/A, not available; T-ALL/LLy, T-cell acute lymphoblastic leukemia/lymphoma; WBC, white blood cell